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ABSTRACT
It has been shown that nitric oxide (NO) directly exposed
to nucleic acids causes deoxypurine deamination leading to
the formation of deoxyinosine and deoxyxanthosine in vitro.
This dissertation describes the synthesis and
characterization of oligonucleotides containing two
deaminated purine products, deoxyxanthosine (dX) and
deoxyinosine (dI). A methodology to assess the mutagenic
potential of these nucleosides in vivo by using site-
specific mutagenesis technology is proposed.
To address quantitatively the issue of deaminated purines
leading to GA or AG mutations, xanthine and inosine were
chemically synthesized and placed into a fragment of the
lacZ gene of the M13 bacteriophage genome. These modified
oligonucleotides containing dX or dI were characterized by
using high pressure liquid chromatography, enzymatic
digestion and mass spectrometry. Mutations induced by these
modified oligonucleotides will give rise to amber codons
providing a convenient means of color selection in an amber
suppressor host. Future research using this methodology
will provide a quantitative investigation of mutations
induced by xanthine and inosine in Escherichia coli.
Thesis Supervisor: Dr. John M. Essigmann
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I. INTRODUCTION
The biological and chemical properties of nitric oxide (NO-)
have been the subject of intense research. New findings
have identified nitric oxide as an important constituent of
neuron transmission, immune defense and many other
physiological functions in man. As result of these
findings, NO- was named "molecule of the year" by the
journal Science in 1992. In moderate concentrations nitric
oxide serves as a secondary messenger or an immunological
cytotoxin. However under conditions of prolonged exposure
to nitric oxide, such as chronic inflammation, DNA damage
and mutations could arise. The possibility of these events
has led to further studies as to the deleterious effects of
this short-lived reactive molecule. Nitric oxide exposed to
naked DNA leads to the formation of two deaminated purines:
deoxyxanthosine (dX) and deoxyinosine (dI) (Nguyen 1992).
Other researchers have directly exposed NO, to organs,
cells, polynucleotides and DNA bases. Their findings
support the conclusion that nitric oxide combined with
oxygen leads to a deamination reaction on DNA bases.
Unfortunately direct exposure of nitric oxide to nucleic
acids produces numerous oxidative DNA lesions, making the
specific contribution of each mutation from deaminated
deoxypurine lesions impossible to measure. To address this
issue, site-specific placement of a chemically synthesized
oligonucleotide containing dX or dI would allow for
unambiguous characterization of mutations, mutation
frequency and lesion repair from these two deaminated
purines. Nucleic acid mutations could be isolated and
quantified using the well characterized lacZ gene mutation
assay. The lacZ gene of the bacteriophage M13 could carry
the modified oligonucleotide containing dX or dI and infect
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Escherichia coli hosts. The analyzed in vivo mutations
would improve existing knowledge of the possible genotoxic
effects of nitric oxide. Oxidative DNA lesions and repair,
nitric oxide attribution and the M13 bacteriophage system
are reviewed. The chemical synthesis of modified purine
oligonucleotides, genome design, construction and
characterization are described in detail.
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II. LITERATURE SURVEY
A. Oxidative stress: Daily exposure and reactive oxidants
Oxidative stress can give rise to the formation of modified
DNA bases, sugars and DNA strand breaks (Hutchinson, 1985).
In general, nucleic acid modifications can be formed by
direct ionization of DNA, or by the indirect effect caused
by reactive species, in most cases free radicals, which are
produced in the vicinity of the DNA. The indirect class of
DNA damage results from exposure to both endogenous and
exogenous oxidizing agents. Reactive oxygen species, in
the forms of superoxide ion (02), hydroxyl radical (OH-),
hydrogen peroxide(H202) and nitric oxide (NO-) metabolites
are formed in vivo as a byproduct of normal aerobic
metabolism (see reviews Joenje, 1989; Sies, 1991; Moncada et
al., 1991). Oxidizing species are also formed during
radiation exposure and through xenobiotic metabolism of
organic carcinogens. A common and reactive oxygen species
generated by water homolysis or metal-catalyzed
decomposition of hydrogen peroxide is the hydroxyl radical
(Halliwell and Gutteridge, 1989). The superoxide anion
radical and conjugated acid forms are ubiquitous in living
systems but have low reactivity toward nucleic acid in a
hydrophilic environment (Cadet and Teoule, 1978).
Similarly, hydrogen peroxide arising from the dismutation of
O2' has the ability to diffuse passively through cell
membranes but is only weakly reactive with nucleic acids
(Cadet, 1994). Reactions involving DNA base deamination are
believed to occur spontaneously or through reactive nitric
oxide species.
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In general lesions formed in DNA by oxidants are very
similar to those formed by ionizing radiation. As a process
of evolution, organisms have developed numerous and complex
defenses against oxidative and radiation damage.
Nevertheless, it has been estimated that the genome of a
rodent and human cell receives about 105 and 104 oxidative
hits per day respectively (Park et al., 1992; Ames et al.,
1993). Oxidative DNA damage leading to mutations has been
implicated in a variety of degenerative disorders including
cancer and aging (Loeb, 1989; Shigenaga et al., 1994).
Below to introduce the topic of oxidative stress research,
DNA lesions induced by hydroxyl radicals or DNA base
deamination are focused upon. In addition, methodologies
for measurement of these oxidative lesions are mentioned
with examples of DNA base excision repair of two commonly
found oxidative lesions.
Methodologies
HPLC or gas chromatography with appropriate spectroscopic
detection techniques have allowed for detection and
characterization of numerous DNA base and sugar lesions (see
Figure 1). The two following methods have been used to
measure oxidative lesions in vitro by exposing isolated DNA,
cells or organs to specific oxidizing agents. Gas
chromatography-mass spectrometry (GC-MS) has successfully
monitored the formation of damage at several purine and
pyrimidine residues of DNA and chromatin exposed to radical
oxidizing agents (Dizdaroglu and Gajewski, 1990; Halliwell
and Dizdaroglu, 1992). Unfortunately a problem with the GC-
MS approach is the high background levels of oxidized
lesions produced subsequent to acid hydrolysis, derivation
and enzymatic digestion of the oxidized DNA base. Another
useful approach is the HPLC-electrochemical detection
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method, which yield 3-8 times lower background levels than
the GC-MS approach (Floyd et al., 1986; Wagner et al.,
1992). Both techniques are used for the measurement of
oxidative DNA damage within cells generally requiring an
assay detection threshold close to one lesion per 105-106
normal bases. Alternatively, assessment of oxidative DNA
damage in humans and animals has been achieved by the global
measurement of oxidized bases and nucleosides released in
urine as a result of DNA repair (Ames and Gold, 1991; Simic
and Bergtold, 1991).
Mutation assays
The assessment of in vivo DNA mutations induced by specific
oxidants can be accomplished by number of methods. One
method involves global exposure of the suspected mutagen to
whole cells or organisms. Two examples are the
Salmonella/mammalian microsome test which is based on
reversion of auxotrophs (Maron and Ames, 1983) and the
hypoxanthine-guanine phosphoribosyltransferase (HPRT)
mutants selected by resistance to purine analogues in
Chinese hamster or human cells (DeMarini et al., 1989). In
addition, various bacterial and bacteriophage gene mutation
assays have been developed in which the nucleic acids are
directly exposed to a specific oxidant and the affected DNA
is re-introduced into a host system. One standard system is
the M13 bacteriophage LacZ gene assay, which has been used
to measure the mutagenic specificity of oxygen radicals
produced by human leukemia cells in culture (Reid and Loeb,
1992). A chemically synthetic approach is site-specific
mutagenesis, which incorporates a single oxidative product
into a gene in vitro and measures the mutagenic contribution
of the individual lesion in vivo (Basu and Essigmann, 1988).
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Deoxypyrimidines
The most susceptible of the DNA bases to free radical
mediated oxidative damage in vitro is thymine. The
5,6 double-bond of thymine is subject to radical attack with
a slight preference for the C-5 position (Fujita and
Steenken, 1981). Unstable thymine hydroperoxides are
initially formed but could become further reduced to 5,6-
dihydro-5,6-dihydroxy thymine, otherwise known as thymine
glycol. Thymine glycol has been found to be the major
radiolysis product when thymine or DNA were irradiated in
vitro (Teoule and Cadet, 1978) and has been identified in
human and animal urine (Adelman et al., 1988). cis-Thymine
glycol was site-specifically positioned in a single-stranded
genome of the M13 bacteriophage and found to form a T-.C
transition (Basu et al., 1989). Other OH induced products
are frequently cis and trans isomers of 6-hydroperoxy-5-
hydroxy-5,6 dihydrothymine and 5-hydroperoxy-6-hydroxy-5,6-
dihydrothymine. The OH' also attacks the 5,6 double bond
of cytosine forming an unstable cytosine and 2'-
deoxycytidine hydroperoxides. Further examination of one of
the oxidized cytosine (5'hydroxy-6-hydro-2'-deoxycytidine)
revealed a disposition of C->T transitions (Wagner, 1992).
Other known oxidized pyrimidine products are:
5-hydroxyhydantoin, 5-hydroxy-6-hydrothymine,
5,6-dihydrothymine, 5-hydroxy-5-methylhydantoin, and
cytosine glycol.
Deoxypurines
In general, purines are thought to be less affected by
hydroxyl radical exposure than pyrimidines. However
oxidized purines are formed and usually occur as:
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8-oxo-7,8-dihydro-2'-deoxyguanine, 2,6-diamino-4-hydroxy-5-
formamidopyrimidine (fapy guanine), 4,6 diamino-5--
formamidopyrimidine (fapy adenine) and 7,8-dihydro-8-
oxoadenine. For OH' damaged adenine, the 7,8-dihydro-8-
oxoadenine is the most abundant lesion formed and has been
isolated in human urine (Stillwell et al., 1989).
Spectrometric studies have shown the 7,8-dihydro-8-oxo-
2'deoxyadenosine to exist mainly as a keto tautomer with the
proton on the N7 atom (Cho and Evans, 1991; Guschlbauer et
al., 1991). Site-specific evaluation of 7,8-dihydro-8-
oxoadenine revealed that it could mispair with dG implying
an AC transversion (Shibutani et al., 1993) but it is not
mutagenic in vivo (Wood et al., 1992). The main products of
OH mediated decomposition of deoxyguanosine are 2,2-
dciamino-4-[(2--deoxy-f-D-erthyo-pentofuranosyl)amino]-5-(2H)-
oxazolone and 2-amino-5-[2-deoxy-3-D-erthyopento-
furanosylamino]-4H-imidazole-4-one (Cadet et al., 1991).
The 7,8-dihyd:ro-8-oxo-2'-deoxyguanine lesion has been found
as a urinary excretion product in man (Degan et al., 1991).
NMR studies have demonstrated that 7,8-dihydro-8-oxo-
2-deoxyguanosine exists in solution as the
6,8-diketotautomer with a preferential syn-glycosidic
conformation (Culp et al., 1989; Cho et al., 1990). Site-
specific incorporation of 7,8 dihydro-8-oxo-2'deoxyguanosine
has been accomplished and it has been shown that the lesion
induces a G-T transversion in vivo (Wood et al., 1990).
DNA deamination
DNA model studies have shown that cytosine components are
much more susceptible to hydrolytic deamination than purine
constituents under neutral and slightly acidic conditions
(Shapiro and Klein, 1966). Cytosine deamination is known to
18
form uracil. Under physiological conditions the cytosine
deamination rate constant for single and double-stranded DNA
has been measured to be 1 X 10-10 and 7 X 10-13 per second
(Frederico et al., 1990). Curiously cytosine deamination
is believed to be 3-5 times slower than 5-methylcytosine
conversion to thymine (Ehrlich et al., 1990). Spontaneous
base deamination has been shown to occur at 5-methylcytosine
residues in the lacI gene of E. coli, giving rise to base
substitution "hot spots" (Coluondre et al., 1978) believed
to occur preferentially at GC sequences. 5-Hydroxy-
methyluracil bases has been found in human urine (Faure et
al., 1993). Other oxidative lesions of uracil derivatives
have been identified such as: 5,6-dihydroxy-5,6-dihydro-
uracil (uracil glycol), 5-hydroxy-2'-deoxyuridine,
5-hydroxyl-methyluracil and 5-formyluracil. The cis and
trans configurations of 5,6-dihydroxy-5,6-dihydrouracil have
been shown to arise from the deamination of cytosine glycol
(Polverelli and Teoule, 1974). The purine base in DNA is
more resistant to spontaneous hydrolysis than pyrimidine
constituents. However purine constituents were found to be
more easily deaminated by nitrous acid than pyrimidine
analogues (Shapiro and Yamaguchi, 1972). The environmental
pollutant and bioregulator nitric oxide is mutagenic and has
been shown to deaminate purine residues (Wink et al., 1991;
Arroyo et al., 1992). Nitric oxide exposure to naked DNA
yields two deaminated purine products, namely deoxyinosine
and deoxyxanthosine (Nguyen et al., 1992). A more
comprehensive review of nitric oxide chemistry and biology
are presented in later sections.
DNA base excision repair
In general, mutations could arise from the misincorporation
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of DNA bases by DNA polymerase or by misrepair or no repair
of DNA lesions. One way cells remove oxidative lesions is
by base excision repair. Glycosylases cleave the bond
between deoxyribose and a damaged or inappropriate base
leading to the formation of an apurinic or apyrimidinic (AP)
site. Specific DNA glycosylases remove particular lesions.
A closer look at the incision-dependent repair reveals four
steps: the phosphodiester-bond cleavage (incision), removal
of one or more nucleotides including the damaged bases
(excision), replacement of the nucleotides by DNA polymerase
(resynthesis) and formation of a phosphodiester bond linking
the newly synthesized region or "patch" to the rest of the
DNA strand (ligation). Two well known DNA base excision
systems in E. coli are examined further with respect to
thymine glycol and 8-oxoguanine repair.
Thymine glycol excision repair
ILn vitro studies of thymine glycol adducts has shown that
this lesion blocks DNA replication (Rouet and Essigmann,
1982). Such an event obviously could lead to cell death.
To cope with the dangers of thymine glycol accumulation,
bacterial cells produce at least two specific base excision
proteins. The first repair protein is endonuclease III
encoded by the nth gene. This enzyme is associated with a
DNA glycosylase specific for 5,6-hydrated thymine moieties,
which include thymine glycol and uracil moieties (Demple and
Linn, 1980; Kather and Wallace, 1983). The function of
endonuclease III is to hydrolyze the 3'-phosphate and 3'-
phosphoglycolate into a 3'-hydroxyl. The xth gene also
encodes the endonuclease III protein and is sometimes
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referred as endonuclease VI. After base hydrolysis, other
proteins replace the AP site with the appropriate base as
explained earlier. In general endonuclease III is a major
AP endonuclease of E. coli. Duplication of essential genes
is a common feature in bacteria as well as in higher
developed organisms.
8-Oxoguanine excision repair
The 7,8-dihydro-8-oxoguanine (8-oxoG) adduct can result in a
misincorporation of an adenine (A) opposite the 8-oxoG. The
MutY gene codes for a glycosylase specific for the A:8-oxoG
mispair. The function of mutY glycosylase is to remove the
misincorporated dA from the A:8-oxoG mispairs that result
from error-prone replication past the 8-oxoG lesion
(Michaels et al., 1990, 1991). A complement to the MutY
protein is the MutM enzyme, also known as the fpg protein.
The fpg enzyme is an 8-oxoG endonuclease (Tchou et al.,
1991). The repair scenario may follow this pattern: the
fpg excises 8-oxoG during the first round of replication.
Any remaining lesions could encounter MutY, adenine
glycosylase, provided adenine is positioned opposite 8-oxoG.
Both the MutY and MutM systems seem to work in concert to
increase the opportunity to remove 8-oxoG and prevent GC-TA
and AT-CG mutations. Studies using double mutants of MutM
and MutY genes have lead a several fold higher mutation rate
than cells missing either glycosylase alone. In addition to
base excision other mechanisms exist for cells to survive
unrepaired lesions such as: postreplication repair,
daughter-strand gap repair, bypass synthesis or trans-lesion
synthesis.
21
Figure 1. A partial list of pyrimidine and purine products
of oxidative damage. Three of the lesions listed
(8-hydroxyguanine, 8-hydroxyadenine and thymine
glycol) have been characterized as to their
mutagenic potential by site-specific mutagenic
techniques.
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B. Biological significance of Nitric Oxide
Mammalian cells as diverse as macrophages (Marletta et al.,
1988), neutrophils (Wright et al., 1989), neurons (Bredt and
Snyder, 1992) and endothelial cells (Moncada et al., 1988)
synthesize nitric oxide from L-arginine while several types
of abdominal bacteria produce nitric oxide by reduction of
nitrite (Calmels et al., 1985). The function of this
compound at low levels is generally beneficial. Nitric
oxide in three different functional capacities is reviewed.
The subjects are endothelium-dependent relaxation (Furchgott
and Zawadzki 1980), neurotransmission (Garthwaite et al.,
1988), and cell-mediated immune response (Nathan and Hibbs,
1991). Schematic representation of NO activity is shown in
Figure 2.
Nitric Oxide Synthase
Nitric oxide is produced endogenously by the action of
nitric oxide synthase (NOS). The production of nitric oxide
can be constitutive or inducible dependent on cell function
(see review Moncada et al., 1991). Brain cells and
endothelial cells have the constitutive form activated by
the regulatory protein calmodulin (Busse and Mulsch, 1990),
which itself is activated by an influx of calcium ions into
the cell. NO released under physiological conditions by
NOS require an electron donor (NADPH) and the cofactor
tetrahydrobiopterin, which are used for the reaction of
molecular oxygen and the amino acid L-arginine. The
interaction involves removal of the nitrogen atom from
arginine and the reaction with an oxygen atom to form NO
and citrulline (reviewed Marletta, 1994). The availability
of L-arginine is well regulated as demonstrated by
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endothelial cells deprived of L-arginine yet are still able
to synthesize this amino acid from endogenous sources
(Hecker et al., 1990; Sessa et al., 1990). Researchers have
extensively used arginine analogues such as
N-monomethylarginine (NMMA) as inhibitors of NOS to help
elucidate the enzyme action.
Endothelial Derived Releasing Factor
Nitric oxide secreted by endothelial cells is generally
referred to as endothelium-derived relaxing factor (EDRF).
EDRF and NO have been found to be the same molecule
(Ignarro and Furchgott 1988). EDRF functions as an
antagonist to smooth muscle contraction by inhibiting
receptor agonist-evoked Ca2+ influx from intracellular
stores (Olsen et al., 1976; Knowles et al., 1989). The
believed mechanism is dependent on EDRF binding to the heme
component of the enzyme guanylate cyclase (Miki et al.,
1977). The activated enzyme then synthesizes the molecule
cyclic guanosine monophosphate (cGMP). The cGMP acts as a
signal that ultimately induces muscle relaxation by cGMP-
dependent protein kinase inhibition of receptors that gate
intracellular Ca2+ concentrations. In the cardiovascular
system the release of NO acts as a general adaptive
mechanism whereby the vascular endothelium responds to
changes in its environment and regulates blood flow and
blood pressure (Radomski et al., 1990). The presence of
EDRF induces vascular smooth muscle relaxation and
consequently lowers blood pressure. EDRF also inhibits
platelet aggregation and adhesion (Azuma et al., 1986).
Some researchers believe NO is bundled to a carrier
molecule that prevents its reaction with oxygen (Stamler et
al., 1992). EDRF interactions in aerobic systems are
discussed in the NO chemistry section.
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Neurotransmission
The importance of the L-arginine:NO pathway in the nervous
system has yet to be fully established. NO in neurons is
not stored, but rather synthesized on demand; its general
action is mediated by diffusion to intracellular targets
rather than by binding to specific plasma membrane receptors
and there is no known inactivation or uptake mechanism
(Schmidt and Walter, 1994). The function of synaptic
plasticity has been suggested by NO interaction with the
N-methyl-D-aspartate (NMDA)-type glutamate receptor which
could attenuate long term potentials (Schuman and Madison,
1991). In the long-term potentiation scenario, glutamate is
released from a presynaptic neuron and binds to the NMDA
receptor on the postsynaptic neuron. The receptor binding
releases a retrograde messenger (NO-) that diffuses back to
the presynaptic neuron, causing a subsequent increase in the
level of cGMP molecule and promotes the release of more
glutamate from the presynaptic terminal. The cycle repeats
itself and enhances the synaptic connection. The human body
coordinates NO expression to cause physiological change.
Neurons use NO to regulate transmitter release of adjacent
neurons (Meffert el al., 1994) and EDRF affects cerebral
blood flow to match neuronal activity all in conjunction
with bronchial epithelial and endothelial cells for
appropriate ventilation and perfusion (Gaston et al., 1994).
Immunology
Resistance to infection and cancer can be enhanced in a non-
specific way by bacterial products, a fact known for more
than a century (Coley, 1893). A later study revealed
macrophages are able to give rise to the observed resistance
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(Old et al., 1961). Macrophages (killer cells) recognize
and destroy host cells that have become infected with a
pathogen. Killer cells respond by ingesting the infected
cell and release cytokines that further activate other cells
or release toxic substances that directly kill the infected
cell. NO has been suspected to be related to this
cytotoxicity (Hibbs et al., 1990). Macrophages possess the
inducible type of NOS. The NO expressed by the cell-
mediate immune response is always non-specific and calcium
independent (Nathan and Xie, 1994). The inducible NOS
produces much greater amounts of nitric oxide than the
constitutive form. This factor is key to the differing
roles of NO in the body. Stimulated macrophages secrete
nitric oxide to a level of 1000 times above normal
constitutive NOS expression (McCall et al., 1989). Nitric
oxide is also related to the cytotoxicity of tumor cells
(Nathan and Hibbs, 1991), which supports the immune-
surveillance theory of cancer. The theory states that an
uncompromised immune system kills tumor cells before they
become malignant. Presented here are the beneficial
attributes of nitric oxide. However, NO, also has
detrimental characteristics as presented in the toxicology
section.
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Figure 2. The biological role of nitric oxide in humans.
This radical serves the body as a secondary
messenger with vastly different functions
according to tissue type and amounts secreted.
Nitric oxide secretion is both inducible and
constitutively produced. Typically NO serves
a normal function in cell signaling, enzyme
regulation and immune interactions. However
NO could also induce mutations in neighboring
nucleic acids under conditions in which
macrophages and/or neutrophils secrete
excessive amounts of nitric oxide. This
occurs in the case of chronic inflammation.
The following symbols NOS, RS-NO, M-NO denote
nitric oxide synthetase, nitric oxide
bound to a thiol group and the metal bound
nitric oxide species, respectively as noted by
Stamler et al., 1992.
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C. Nitric Oxide chemistry
Nitric oxide is an inorganic gas ubiquitous in the human
body. Under physiological conditions NO' can cause DNA
damage in several ways: 1) interactions with electrophiles
arising from metabolism of N-nitroso compounds,
2) nitrosation of amines on nucleic acid bases leading to
deamination or 3) attack by active species arising from
reactions of nitric oxide with endogenous oxygen radicals
(see Figure 3).
Nitric Oxide half-life and diffusion distance
Cells do not appear to possess an enzymatic mechanism for
NO removal (Schmidt and Walter, 1994). One reason could be
the short half-life of this molecule. Nitric oxide is only
a two atom molecule and has electrical neutrality, which
allows its easy passage through biological membranes
facilitating its action in cell signaling. The half-life of
nitric oxide and the diffusion length seems to be largely
dependent on the cellular location, concentration of nitric
oxide and the local environment. For example, t1/2 has been
reported as short as 0.1 sec to 4 sec or longer at
physiological conditions (Lancaster, 1994) and diffusion
distances range from < 160 m in cell-cell communication
to >500 m for cell to blood diffusion (Saran and Bors,
1994). Given cell diameters of 10-20 m/cell, NO has the
capacity to travel to as few as 8 to as much as several
thousand cells. Reaction with protein-thiol groups form S-
nitroso derivatives that function like NO and have
implications for a longer-lived molecule (Stamler et al.,
1992).
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N-Nitroso compounds
Endogenous formation of N-nitroso compounds have been
extensively studied. N-Nitrosamines are well-known chemical
carcinogens that are metabolized to strong alkylating
electrophiles that react with DNA at several nucleophilic
sites (reviewed Zimmerman, 1977). The alkylation spectra
vary from agent to agent, but reactions at the N-7 and 0-6
positions of guanine and the N-3 position of adenine
typically predominate (Pegg, 1977).
Historically, amine nitrosation in lab settings were
accomplished with acidic nitrite. The actual nitrosating
species for amines is N203 (Pegg, 1977; Challis et al.,
1989). The overall rates for amine nitrosation reactions go
through maxima near pH 3.5, reflecting increasing
concentrations of nitrosating species and a decreasing
concentration of free amine as the medium become more acidic
(Mirvish, 1975). Nitric oxide and the resulting
nitrosations are examples of chemical pathways that were
elucidated by Challis and co-workers, 1989. An effective
nitrosating agent for primary and secondary amines under
non-acidic conditions is N203. Reactions with secondary
amines form N-nitrosoamines in aqueous and organic solutions
in vitro and for an number of nitric-oxide generating cell
systems in culture, including bacteria (Calmels et al.,
1987) and macrophages (Iyengar et al., 1987). Reaction with
aryl diazonium ion of the base undergoing deamination with a
nucleophilic site on an adjacent macromolecules could lead
to crosslinking with other nucleic acids or with proteins
(Kirchner et al 1992).
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Oxygen radicals related to Nitric Oxide
DNA damage by oxygen radicals that may be formed from nitric
oxide has been difficult to establish in detail. There is
increasing evidence that such reactions occur. For example,
several nitric oxide-related processes can be attenuated by
superoxide dismutase, indicating that the superoxide anion
radical is involved (Heinzel et al., 1992; Pou et al.,
1992). Superoxide alone is weakly reactive to DNA bases
(Cadet and Teoule, 1978). Reaction of superoxide with
nitric oxide to form peroxynitrite has been demonstrated
(Blough and Zafiriou, 1985; Beckman et al., 1990). Also
hydroxyl radicals arising from superoxide via Fenton-or
Haber-Weiss-like chemistry has been suggested as the active
species (Imlay, 1988). Evidence has also been cited that
the crucial process involves generation of hydroxyl radical-
like compounds (Koppenol et al., 1992) by decomposition of
peroxynitrite formed by the direct reaction of superoxide
and nitric oxide (Saran et al 1990). However, arguments for
oxidants other than the hydroxyl radical and the
peroxynitrate anion as the reactive species in the NO/0 2
reaction have been cited by others (Wink et al., 1991, 1993;
Pryor et al., 1994).
Assuming peroxynitrite is formed, a number of possible
reactions can occur (reviewed by Plumb et al., 1992).
Peroxynitrite, with a pKa of 6.8, is protonated in acidic
solution to form peroxynitrous acid that can decay rapidly
to predominately nitrite. The mechanism has not been
completely elucidated but it appears to involve a
combination of isomerization and radical formation-
recombination. The reaction in base leads to nitrite as the
major product along with molecular oxygen and proceeds
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slowly unless metal ions are present. The controversy
concerning whether peroxynitrite releases hydroxyl radicals
per se or gives rise to unstable reactive intermediates,
(isomers of peroxynitrite anion, Beckman et al., 1992), does
not distract from the biological observations that NO DNA
damage is similar to hydroxyl radical induce damage.
Nitric Oxide induced DNA base deamination
Purines and pyrimidines (and their derivatives) containing
an amino group treated with nitrous acid yield unstable
diazonium salts. The diazo intermediates are readily
decomposed to form deaminated compounds such as inosine,
xanthosine and uridine respectively, from adenosine,
guanosine and cytidine (Kochetkov and Budovskii 1972). As
noted in the biology section, NO is generated in vivo by
the reactions of NO2 with oxygen or by the reaction of other
nitrogenous precursors (e.g., arginine) with reactive oxygen
species. Through subsequent chemical reactions, the potent
electrophile N203 could be formed, which can deaminate
cytosine, 5-methylcytosine, guanine and adenine in DNA (Wink
et al., 1991) see Figure 4. In particular the suspected
deaminated purine products are thought to be deoxyxanthosine
and deoxyinosine (Nguyen et al., 1992). The deaminated
bases formed by this reaction pose potential mutagenic risks
as noted in the toxicology section.
Nitrosative deamination is a well-known consequence of the
reaction of primary amines with acidic nitrite (Obiedzinski
et al., 1980). The nitrosating species, N203 generated from
nitrous acid, will occur under non-acidic conditions when
N203 is generated in the presence of primary amines
(reviewed Tannenbaum et al., 1994). Nitrosation of primary
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amines results in rapid deamination via diazonium ions and
diazohydroxides. Deamination by this mechanism is possible
in principle with most purines and pyrimidines; an exocyclic
amino group is the principle structural requirement.
Deoxyxanthine chemistry
Xanthosine with a pK of 5.7 exists in the diketo tautomeric
form in aqueous solution at pH 5 and the 6-keto-2-enolate
anion structure at neutral and slightly basic pH (Roy and
Miles, 1983). When deoxynucleosides are treated with
nitrous acid, an important side reaction is cleavage of the
N-glycosidic bond in the deaminated products (Kochetkov and
Budovskii, 1972). In particular, deoxyxanthosine has been
noted to have high acid lability of its N-glycoside bond
(Shapiro and Pohl, 1968). Comparison of deaminated
deoxypurines at pH 3.35 and 37 C demonstrated that 56% of
deoxyxanthosine is converted in 2 hours into xanthine,
whereas deoxyinosine yields 54% hypoxanthine in 24 hours
(Shapiro and Chargaff, 1966). The first order velocity
constant for acid hydrolysis of 2'-deoxyxanthosine-5'-
phosphate and 2'-deoxyinosine-5'-phosphate is 9.7 X 10-5
moles/sec and 3 X 10-6 moles/sec, respectively (Kochetkov and
Budovskii, 1972). Hydrolysis of the N-glycosidic bond in a
nucleoside leaves an abasic site that could be cleaved by an
endonuclease or by base catalysis to yield a DNA single-
strand break. Alternatively, the abasic site could "pair"
with adenine during replication (Loeb and Preston, 1986).
Depurinated DNA base mispairs
As noted earlier, deoxyuracil, deoxyxanthosine (dX) and
deoxyinosine (dI) are implicated DNA deamination products
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produced by nitric oxide that can form DNA mispairs (see
Figure 5). Eritja et al. (1986) used Drosophila melangaster
DNA polymerase to measure relative nucleoside
incorporation rates opposite deoxyxanthosine. Also in the
same study, the melting temperature of duplex
oligonucleotides containing X:T, X:G, X:C, and X:A basepairs
at neutral pH are reported. Thermodynamic stabilities of
the mispairs are in the order of T>G>A = C and
deoxynucleotide incorporation at the site opposite to dX
shows a preference of T>C>A = G. The nucleoside
incorporation did not correspond well with base stability
except for the X:T mispair. Stability studies done with
deoxyinosine mispairs display the order of stability as I:C>
I:A> I:T = I:G (Martin et al., 1985; Aboul-ela and Tinoco
Jr. 1985). Hypoxanthine behaves approximately as a guanine
analog in nucleic acids (Martin et al., 1985). NMR studies
confirmed the formation of a dI(syn):dG(anti) base pair in a
B-DNA helix (Oda et al., 1991). The NMR study and a
sequence dependent study of two adjacent deoxyinosines
(Case-Green and Southern, 1993) support the idea that
hypoxanthine can form hydrogen-bonded base pairs with all
four normal DNA bases.
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Figure 3. Possible pre-mutagenic events pertaining to
nitric oxide chemistry. Oxidative damage of
DNA bases is believed to involve the Haber-
Weiss reaction. NO-, oxygen and a transition
metal could produce highly reactive hydroxyl
radicals leading to oxidative lesions, strand
breaks and cross-links. The question mark (?)
denotes the uncertainty as to the ultimate
reactive species of nitric oxide and oxygen.
Alternatively, nitric oxide could also react
with primary or secondary amines yielding N-
nitroso compounds or a deamination reaction.
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N203 + N204
Figure 4. Possible DNA base deaminations induced by
nitric oxide exposure. Purine deamination is
the focus of this study. Specially, the
possible mutagenic potential of
deoxyxanthosine and deoxyinosine is under
study.
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Figure 5. Wobble base pairing of xanthine and inosine
with pyrimidines. Xanthine is believed to
base pair with thymine to yield a guanine to
adenine transition. Similarly, inosine can
mispair with cytosine giving the potential of
an adenine to guanine transition.
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D. Nitric Oxide toxicology
Cytotoxicity, cytostasis and DNA damage have been associated
with both beneficial and harmful effects of nitric oxide.
The ultimate cellular consequence is largely determined by
the relative concentration of nitric oxide and cellular
sensitivity to this chemical. The two categories of injury
are presented along with several suggested examples of
possible NO damage accounting for pathophysiological trauma
or disease.
NO' induces cytotoxicity and cytostasis
The immune system deploys NO to kill or inhibit growth of
foreign organisms. Macrophages, which elicit cytotoxic
effects, have been measured to secrete NO on the order of
5 X 103 to 5 X 104 molecules/cell-sec (Marletta et al.,
1988). Ironically the generated NO' could also have adverse
effects on host cells induced to express the NO synthase or
in adjacent cells. Macrophages in which this pathway has
been induced show signs of NO' dependent toxicity (Higgs et
al., 1990). The mechanism of NO leading to cell death or
cellular dysfunction is being actively pursued.
One of method to explain the toxicity involves nitric oxide
binding to metal atoms (reviewed by Lancaster, 1992).
Research by Nathan and Hibbs (1991) demonstrated that cells
killed by macrophages lose the function of certain iron-
bearing enzymes. This physical property of nitric oxide
binding to the metal-center of enzymes could possibly
inhibit catalysis involved in cellular respiration. This
action suggests that target cells stop working properly and
lead to cell starvation. Excessive NO' could also induce
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hyper-activity of normal physiological functions. For
instance septic shock, an affliction initially caused by
bacterial toxins that enter the blood circulation, triggers
a systemic immune response that lowers blood pressure (EDRF
function) to the critical point of vital organ failure.
In a non-immune response, Bredt and Snyder (1992) proposed a
model to account for massive neuron death after certain
types of head trauma. Excitotoxic death is a condition
where large amounts of the excitatory amino acid glutamate
released into synaptic sites causes neurons to excite
themselves to death. The release of glutamate activates
receptors and a large amount of calcium influx ensues, which
activates nitric oxide synthase through the enzyme's
dependence on calmodulin. Consequently, the massive amounts
of nitric oxide released into the region probably destroy
neurons by binding the metalloproteins significant to
cellular metabolism.
DNA mutation
Another possible mechanism to account for the etiology of
human diseases is genetic mutation (Zimmermann, 1977).
Nitric oxide exposed to Salmonella has been shown to be
mutagenic (Arroyo et al., 1992). As noted in the chemistry
of nitrous acid, deamination of DNA residues are prevalent
after NO exposure. ATGC transitions could arise from
adenine conversion to hypoxanthine (Ohtsuka et al., 1985;
Hill-Perkins et al., 1986; Kamiya et al., 1992a) and GC->AT
transitions could result from deamination of cytosine to
uracil (Duncan and Miller, 1980), of 5-methylcytosine to
thymine (Coulondre et al., 1978), and guanine to xanthine
(Eritja et al., 1986; Kamiya et al., 1992b).
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The strongest evidence in support of the deamination
mechanism of DNA damage is probably the direct observation
of deamination products following treatment of cells or
naked DNA with nitric oxide in the presence of oxygen.
Mutations caused by nitric oxide treatment of S. typhimurium
appear to be associated largely with conversion of 5-
methylcytosine to thymine (Wink et al., 1991). However, a
later study argued against the deamination of cytosine or 5-
methylcytosine as the mechanism of nitric oxide mutagenicity
(Schmutte et. al., 1994). Nitric oxide-induced mutations in
a human lymphoblastoid cell line (TK6) were accompanied by
the formation of xanthine and hypoxanthine that presumably
arose via deamination of guanine and adenine, respectively
(Nguyen et al., 1992). Mutations induced by saturated
aqueous nitric oxide in the pSP189 supF gene in human and
E. coli cells found a majority of AT-GC transitions followed
by GC->AT mutations (Routledge et al., 1993). The method of
NO delivery seem to influence the type of DNA transitions
observed as noted by Routledge et al., 1994. The same
plasmid pSP189 at pH 7.4 exposed to NO donor drugs revealed
GCAT transitions as the most abundant mutation. By
contrast, in previous work ATGC transitions predominated
when nitric oxide gas was bubbled through the plasmid
solution under otherwise identical conditions.
Initial site-specific mutagenic studies gave further support
of xanthine and hypoxanthine giving rise to the above
suspected mutations. Kamiya et al. (1992a) studied
deoxyinosine in the codon 61 of c-Ha-ras gene. Deoxyinosine
containing oligonucleotides were transfected into NIH3T3
cells and the DNA was amplified by PCR. The study revealed
a predominance of AG transitions after analyses of 20
clones. Using the same technique, Kamiya et al. (1992b)
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constructed a synthetic c-Ha-ras gene with deoxyxanthosine
positioned in codon 12. The results showed an almost
exclusive GA transition mutational event after analysis of
17 clones. This dissertation proposes a more quantitative
site-specific study as further explained in the discussion
section.
DNA repair of inosine and xanthine
DNA repair systems in biological organisms are believed to
have evolved as a result for the need to reduce mutagenic
and toxic lesions induced by DNA damaging agents. Repair
mechanisms for the removal of dX and dI are important as
explained above. A DNA repair enzyme that specifically
removes uracil from DNA, is uracil-glycosylase present in
both bacterial and mammalian cells (Lindahl, 1974; Sekiguchi
et al 1976; Olsen et al., 1991). Uracil DNA glycosylase has
been shown to remove hypoxanthine (Karren and Lindahl 1980);
a specific hypoxanthine DNA glycosylase has also been
discovered (Karran and Lindahl, 1978), which suggests that
hypoxanthine may be a significant genetic threat in vivo.
There is preferential excision-repair by hypoxanthine-DNA
glycosylase of I:T base-pairs which are removed 15-20 times
faster than I:C pairs (Dianov and Lindahl, 1991). The
characteristics of this excision repair are surprising
considering I:C base pairs are the most stable (Aboul-ela
and Tinoco Jr, 1985) and would lead to the expected AG
mutation. At present no specific DNA glycosylase has been
found for deoxyxanthosine, and this adduct is not removed by
hypoxanthine glycosylase (Karren and Lindahl 1980).
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Cancer
In tissue undergoing an inflammatory reaction, both the
infiltrating and resident cell populations produce a time-
dependent radical species that may contribute to DNA damage.
Although the flux of radicals per unit time is low, an
inflammatory condition that continues for years becomes a
significant risk factor for carcinogenic cell
transformation. Two organs, stomach and lung are exposed to
relevant amounts of exogenous NO' via inhalation of NO' from
ambient air and local synthesis in nasopharynx epithelium
(Schmidt et al., 1994). The stomach has access to both
endogenous (epithelial NOS) and exogenous sources via
conversion of nutritional nitrate by facultative anaerobic
bacteria to nitrite and could lead to a predisposition for
stomach cancer (Esumi and Tannenbaum, 1994). The collection
of changes that might be induced in DNA by the mechanisms
described in the nitric oxide chemistry section could lead
to several types of mutations that are known to be important
in human cancer genes. A great deal of attention has been
paid recently to the p53 tumor suppressor gene, which is of
predominant importance for a number of human cancers
including colon, liver, breast and lung (Hollstein et al.,
1991).
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E. General methods for site-specific mutagenesis:
Biological evaluation of a single DNA adduct
As mentioned in the Introduction, site-specific mutagenic
studies allow for the measurement of the mutagenic potential
or repair of a single DNA lesion. A general description of
site-specific mutagenesis is presented (specific details on
genome design, construction and xanthine modified pentamer
synthesis are presented in the Methods section). Modified
oligonucleotides and unmodified controls will be inserted
into a derivative of the genome of the bacterial virus M13.
Later, specialized vectors will be constructed for
evaluation of the mutagenic processing of DNA lesions in
prokaryotic cells. The technology for the construction and
characterization of site specifically modified genomes was
developed in Essigmann laboratory (see Green et al., 1984
and Wood et al., 1990, for typical details). Assembly of
the M13 genome to be used for these studies will involve:
(1) construction of a five-base gapped heteroduplex genome
with complementary DNA bases for a pentamer insert, and (2)
complete chemical synthesis of a pentamer sequence
containing a single DNA adduct, and (3) ligation of the
pentamer with the adduct into the gapped heteroduplex
forming a singularly modified genome. This modified genome
is then incubated in an in vitro system or transfected into
a receivable host in vivo allowing for biological evaluation
(see Figure 6).
Site-specifically situated versus randomly distributed DNA
adducts
As mentioned in the oxidative stress section, global
modification can not definitively ascribe a specific genetic
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event to a specific DNA adduct. Synthetic chemistry and
biomolecular techniques have made it possible to construct
biologically active singularly modified genomes (Fowler et
al.,1982, Green et al., 1984; Loechler et al., 1984;
reviewed in Basu and Essigmann, 1988). These tools can be
used to address the questions of what effect a specific
adduct has on DNA replication and mutagenesis, and what role
DNA repair plays in modulating those effects.
Site-specific modification of oligonucleotides
There are several methods for producing a site specifically
modified genome and each requires the synthesis of an
oligonucleotide which contains a chemically modified
nucleotide. The three most common oligonucleotide synthetic
strategies are: (1) total synthesis, which involves the
production of a modified protected monomer that is used in
the solution or solid phase synthesis of oligonucleotide,
and (2) chemical or physical modification of a preformed
oligonucleotide, and (3) enzymatic synthesis in which DNA or
RNA polymerase are used to incorporate modified nucleotides
into the oligonucleotide. The total synthetic approach is
often preferred because it enables both the facile
production of sufficient amounts of the adduct in any
desired sequence context. The choice of a method, however,
depends on the chemical nature and stability of the adduct
to be studied. For example, some adducts are unstable under
the conditions required for total synthesis, making this
approach unfeasible with current technology. Similarly, the
treatment of a preformed unmodified oligonucleotide with a
DNA damaging agent may yield products too numerous to allow
this approach to be used effectively. The modified
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oligonucleotide used for the work presented in this
dissertation was prepared by the first method described
above. The DNA sequences chosen, and the rationale for
their selection, will be presented in the Methods section.
The oligonucleotides can be situated in a viral genome
context by using one of below mentioned methodologies.
Methods for construction of singular modified genomes
Modified oligonucleotides can be incorporated into the
genomes of viruses or plasmids in several ways. In one
common method, the oligonucleotide is annealed to the single
stranded genome of a viral vector. The 3' terminus of the
oligonucleotide then acts as a primer for the complementary
strand synthesis by a DNA polymerase. DNA ligase is used to
seal the nick resulting from complete complementary strand
synthesis. This method has been used to construct genomes
containing site-specifically situated thymine dimers (Huang
et al., 1992), psoralen DNA adducts (Kodake and Gamper,
1988). A factor that could limit the usefulness of this
approach is secondary structures present in the M13 genomic
DNA. M13 DNA assumes secondary structural elements of
sufficient stability to prevent efficient replication of the
M13 genome (Reckmann et al, 1985). The holoenzyme form of
the T4 polymerase can be used to overcome secondary
structure problems associated with M13 replication (Kodakek
and Gamper, 1988; Szymkowski et al., 1992). Unfortunately
the proteins comprising the T4 DNA polymerase holoenzyme are
not easily available in their native forms, further limiting
the usefulness of this method. An additional drawback of
the construction of singly modified genomes by using this
approach is the ds nature of the construct produced. M13 ds
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genomes are susceptible to strand replication bias effects
that prevent a single replication blocking adduct (bulky
adduct) from being replicated during DNA synthesis. As a
result, M13-derived ss genomes are preferred substrates for
site-specific studies of replication blocking lesions and
for DNA repair free mutagenic studies.
Another method used for construction of singular modified
genomes, a duplex genome is constructed in which one strand
contains a gap opposite a sequence that is complementary to
that of the modified oligonucleotide to be used. The
modified oligonucleotide is annealed to the gapped duplex
genome and the nicks on either side of the oligonucleotide
are covalently joined by DNA ligase. This method can be
adapted to produce ss genomes by engineering a non-ligatable
nick in the strand not containing the adduct. The nicked
strand can by removed by heat denaturation. This technique
was adopted in the genome engineering scheme presented in
this thesis. A third technique involves the digestion and
removal of the hairpin region of the M13mp7L2 ss genome with
Ecori I, followed by annealing and ligation of the modified
oligonucleotide into a gap formed with the aid of a scaffold
oligonucleotide (Banerjee et al., 1988; LeClerc et al.,
1991).
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F. M13 bacteriophage and the lacZ' gene mutation assay
The vector to be used in the mutagenic study of the single
lesion is the M13 system developed by Messing (1983) and
adapted for use in site-specifically modified genome
construction by C. Lawrence and coworkers (Banerjee et al.,
1988; LeClerc et al., 1991). The following is a short
description of the biology of the bacteriophage M13 and of
the relevant modifications made in the phage genome to
facilitate its use as a cloning vector (Meyer and Geider,
1982; Messing, 1983; Zinder and Horiuchi, 1985) and vehicle
for the lacZ' mutation assay.
M13 life cycle and replication
M13 is a ss F-specific filamentous bacteriophage that
infects E. coli harboring a F factor plasmid. After
infection, the rod shaped phage adsorbs to the F pilus of
the host and the coat proteins are removed as the circular
strand of the DNA enters the cell. The phage DNA is the
template for synthesis of the complementary DNA (-) strand
by the host cell replication apparatus, producing a double
stranded replicative form (RF) molecule. The M13 RF serves
as a template for replication, by a rolling circle mechanism
(Figure 7) and for transcription of the mRNA species
encoding viral proteins. The protein product of the M13
gene II is required for rolling circle replication. It
cleaves the (+) strand at a specific site, and the 3'
terminus thereby produced then acts as the primer for
replication by the host cell machinery. The 5' end of the
(+) strand is displaced as the apparatus moves around the
(-) strand template. Once the replication apparatus has
returned to the origin, termination occurs when the
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displaced (+) strand is cleaved and its 5' and 3' ends
subsequently are ligated to form a genome-length ss circle.
The double stranded RF is sealed and supercoiled, and can
again serve as a substrate for gene II and the replication
apparatus. Early in infection, the (+) strands formed are
replicated to produce RF molecules. Later in the infection
process (after approximately 15-20 min), the cellular levels
of the product of viral gene V, a single stranded DNA
binding protein, are high enough that all of the newly
displaced (+) strands are sequestered by the protein, and
are thus unable to enter the replication cycle. In this way
a steady state level of 100-200 molecules of RF are
maintained in the cell. The gene V protein-coated (+)
stands are translocated to the cell membrane, where the
viral coat proteins are embedded and the DNA is packaged and
finally excluded from the cell. M13 phage does not lyse its
host. The plaques seen when the phage are plated are
actually areas of slowly growing infected cells. Because
the M13 bacteriophage is not packaged into preformed
capsids, but rather are encapsidated as it emerges from the
cell, DNA of almost any length can be packaged. The M13
genomes also contain a small intergenic "polylinker cloning"
region into which DNA can be inserted without adverse
effects to phage viability. Messing (1983) took advantage
of the characteristics of this region in his development of
a series of M13 molecular cloning vectors.
Strand bias effects
The viability of bacteriophage M13 genomes in the ds form
could lead to a phenomenon known as mutational strand bias.
Strand bias effects arise from the ability of either strand
of M13 to give rise to progeny independent of the other
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strand. As a consequence, a replication blocking lesion in
either strand can render the strand inactive and direct the
formation of all progeny from the other undamaged strand. A
replication blocking lesion in a ds M13 genome could not be
replicated and bypassed and its mutagenic effects would not
be exhibited. This liability can be avoided by constructing
a ss genome containing the DNA lesion; with no undamaged
strand present to serve as a template for replication, the
adducts must be replicated from the M13 genome to be viable.
Also ss genomes maximize potential mutation detection by
reducing or eliminating DNA repair.
The M13 lacZ' forward mutation assay
Forward mutational assays in non-essential genes have the
ability to detect a wide arrange of single-base
substitutions, as well as other classes of mutagenic agents
such as insertions and deletions at a large number of sites.
A forward mutational assay is essential in order to detect
subtle difference that might exist in the mutation spectra
of similar compounds. The lacZ' forward mutational assay
utilized in this study has been employed by others to
examine the mutagenicity of a variety of DNA damaging agents
including UV irradiation (Le Clerc and Istock, 1982; Le
Clerc et al., 1984), singlet oxygen (Decuyper-Debeergh et
al., 1989), oxygen radicals (Reid and Loeb, 1992), aflatoxin
(Sahasrabudhe et al., 1989), 4-aminobiphenyl (Lasko et al.,
1988), and apurinic/apyrimidinic (AP) sites (Kunkel, 1984).
A survey of these studies revealed that the lacZ' forward
mutational assay is a sensitive and broad target for the
detection of mutants, with 141 single-base substitutions
detected at 98 different sites along with additional
insertions and deletions.
53
Molecular basis of lacZ' mutational assay
The lacZ' forward mutational assay is based on a series of
proteins that have -galactosidase activity. Mutants that
disrupt the -galactosidase activity of these proteins are
phenotypically identified colorimetrically in the M13 plaque
forming assay. Wild-type -galactosidase encoded by the
lacZ gene of the E. coli lac operon is enzymatically active
as a protein that cleaves -galactosyl bonds (Kalnins et
al., 1983). The active -galactosidease form is a tetramer.
Certain strains of E. coli are chromosomally deleted of the
lac operon but carry the F' lacZ' M15 episome that codes for
production of the M15 protein. M15 is a naturally occurring
mutant of -galactosidase lacking amino acid residue 11-41.
The M15 protein exists as a dimer in solution but is unable
to form tetrameres and, despite a strong substrate binding
site, lacks enzymatic activity (Langely et al., 1975).
The M15 protein attains -galactosidase activity in a
process known as a-complementation. By definition, this
process is the restoration of biological activity by the
non-covalent interaction of two or more different proteins.
In this case, a-complementation involves two polypeptides,
an a-acceptor and an a-donor as shown in Figure 8. When the
M15 protein functions as the a-acceptor, the a-donor can be
any of several peptide fragments containing the amino acids
11-41 that are deleted from M15; for example peptide
fragments 3-92 or 3-41 of wild-type -galactosidase (Welpy
et al., 1981a). The donor utilized in the M13 lacZ'
mutational assay is supplied by the lacZ' polypeptide
encoded by the modified M13 bacteriophage genome created by
Messing et al. (1983). The lac regulatory region and the
first 146 amino acid residues of the lacZ gene produced by
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Hind II restriction of the E. coli lac operon DNA was
inserted into the major intergenic region of the M13 genome.
The peptide coding region has been further elongated by the
addition of a polylinker cloning region in the series of M13
derivatives. The M13 lacZ' polypeptide fragment, comprised
of 164 amino acid residues, is considerably longer than
required for the -complementation process. The lacZ'
polypeptide can be divided into three regions, the N-
terminal overlap, the M15 host deletion, and the C-terminal
overlap. It is well established that the overlapping
regions are not essential for -complementation because the
polypeptide encoded by these DNA sequences is duplicated in
the M-15 a-acceptor protein. This polypeptide chain
required to attain -galactosidase activity can be supplied
by either the M15 a-acceptor or the M13 lacZ' -donor
polypeptide (Zabin, 1982., Welpy et al., 1981b). The
significance of these regions of the M13 lacZ' DNA sequence
to the mutational assay is that the N and C terminal
overlapping regions are not expected to be as sensitive to
the detection of mutations as the lacZ' DNA sequence coding
for amino acids deleted from the M15 -acceptor protein. In
addition, the lacZ's regulatory region is also expected to
give rise to detectable mutations. Mutations in the
ribosome binding site, for example influence the production
of mRNA, resulting in expression of activity ranging from
1-130% of wild-type, depending on the mutation (Guillerez et
al., 1991).
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Figure 6. General construction and uses of site-
specifically modified genomes. Schematic
illustration denotes modified oligonucleotide
ligation into a gaped heteroduplex and
subsequent biological evaluation of the
specific lesion under study.
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Figure 7. Outline of the life cycle of the M13
bacteriophage (from Bradley, 1991). The
natural infection of an E. coli cell by the
single stranded viral form of the M13
bacteriophage genome is shown.
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Figure 8. Molecular basis of the lacZ' mutational
assay. The lacZ' -complementation
process restores -galactosidase activity to
the M15 protein. When complemented with the
wild type lacZ' polypeptide, the M15 protein
tetramerizes and attains P-galactosidase
activity that is observed phenotypically by
the cleavage of the X-gal prochromophore
resulting in the formation of blue plaques
when plated with E. coli GW5100 cells in the
plaque forming assay. If the DNA sequence
has been mutated, the lacZ' polypeptide may
not be synthesized (due to a nonsense
mutation in the coding region or by
disruption of the regulatory region
upstream of the coding sequence) resulting in
colorless plaques. Alternatively, the lacZ'
polypeptide may be synthesized, but be
functionally compromised, resulting once
again in no -galactosidase activity
(colorless plaques) or in some cases
diminished activity (light blue plaques).
This schematic illustration is a
representation of the lacZ' mutation
assay (Yarema, 1994).
60
Wild type lacZ' M13mpl9
DNA sequence
- .
49
Mutated lacZe M13mp19
DNA sequence
I
-- t - I
IPTGIPTG
or
Wild type lacZ' polypeptide
+t
03 0,0 M15 a-acceptorprotein
lacZ' polypeptide Is
defective or absent
f00
$
a-complementation
pgalactosidase activity
Blue plaques
Little or no
a-complementatlon
Little or no fgalactosidase
activity
Colorless or light blue plaques
61
00
III. MATERIALS AND METHODS
The experimental system and strategies to be used for the
proposed studies can be summarized as: the synthesis of
chemically protected deoxyxanthosine, deprotection of
deoxyxanthine contained in a pentamer sequence, stability
studies of dX or dI modified pentamers, M13 genome design
and construction.
A. Materials
Restriction endonucleases (except for PstI and SacI, from
Boehringer-Mannhein), T4 polynucleotide kinase and T4 DNA
ligase were purchased from New England Biolabs.
Phosphatases and DNAses were from Sigma. The E. coli cell
lines used were: DL7 (AB1157; lac U169, uvr+, from D. Lasko
(1986), MIT) and GW5100 (JM103; P1-, from G. Walker, MIT).
Bacterial culture media was from Difco Laboratory. M13mp19
bacteriophage genomes were a gift from J. Messing.
Sequencing reagents (Sequenase) were obtained from United
States Biochemical Corporation. The oligonucleotides used
as sequencing primers were purchased from New England
Biolabs or synthesized by the Biopolymers lab, MIT, and
purified by high-pressure liquid chromatography.
Chemical reagents used for 2'-deoxyxanthosine synthesis are
listed with corresponding vendor in parenthesis:
deoxyguanosine (Penninsula Labs, Inc), acetic anhydride
(Mallinckrodt), pyridine distilled over calcium hydride,
nitrophenolethanol (Aldrich), triphenylphosphine (Aldrich),
sodium nitrite (Mallinckrodt), acetic acid (Fisher), acetone
(Aldrich), distilled water, dioxane distilled over 4A°
molecular sieves, argon (Airco), ammonium hydroxide
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(Aldrich), methanol (Mallinckrodt), dimethoxytrityl chloride
(Aldrich), methylene chloride distilled over calcium
hydride, benzene (Mallinckrodt), bis-diisopropylamine 2-
cyanoethyl phosphosamidite (Aldrich) and diisopropylammonium
tetrazoldide (Dr. Marjie Solomon).
Other laboratory chemicals and reagents where purchased from
Mallinckrodt, with the following exceptions. IPTG and X-gal
were purchased from Gold Biotechnology (St. Louis, MO) or
Biosynth International (Skokie, IL). DNA purification
systems were from the QIAGEN or Promega corporations.
Oligodeoxynucleotides used in the construction of xanthine
modified genomes were synthesized by Mr. William Kobertz,
MIT. All other pentamers were synthesized by using Applied
Biosystems reagents and a Model 391 DNA synthesizer PCR mate
(Applied Biosystems) or by the Biopolymers Lab, MIT. Semi-
preparative HPLC purifications were done on a Waters
Associates model 440 detector linked to a Gateway 2000
computer for peak integration and a Beckman llOB solvent
delivery model. Analytical HPLC runs deployed a Hewlett
Packard model 9133 computer with a 1040A multi-wavelength
detection system, Beckman 421A solvent controller and a HP
9000-300 integrator. Ultrafree probind (Millipore) 0.45 m
filter units with modified PVDF membrane for nucleic acid
purification were used prior to HPLC injection. Pure
oligonucleotides for spectrometry analysis were desalted
using a Sep-pak cartridge (Waters Division of Millipore).
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B. Preparation of xanthine modified oligonucleotide
Generally complete chemical synthesis of modified
nucleosides is the conventional technique used to obtain a
single lesion (deoxyxanthosine) in a specific DNA sequence
for future mutagenic or repair studies. Although enzymatic
synthesis of deoxyxanthosine from mammalian tissues has been
described (Friedkin, 1952), only chemical synthesis allows
for precise placement of the modified nucleoside into an
oligonucleotide. The chemical synthesis of deoxyxanthosine
has been achieved (Moschel and Keefer, 1989). However to
realize a chemically protected 2'-deoxyxanthosine, two
methodologies describing p-nitrophenylethyl protection
(Van Aerschot et al., 1987) and 2'-deoxyguanosine oxidation
(Eritja el al., 1986) were utilized. The following
synthesis of 2'-deoxyxanthosine (see Figure 9.) and
subsequent integration of this nucleoside into a pentamer
oligonucleotide was accomplished by Mr. William Kobertz.
Chemical synthesis of protected 2'-deoxyxanthosine:
5',3'-o-Diacetyl-deoxyguanosine (1)
Deoxyguanosine (2.08 g, 7.25 mmol) was dissolved in 100 ml
of pyridine under argon. Acetic anhydride (20 ml, 212 mmol)
was added and the reaction stirred at room temperature for
72 hours. The white glossy precipitate was filtered and
washed with warm pyridine and anhydrous ethyl ether. The
solid was heated under vacuum overnight to afford 1.75 g
(68%) of a flaky white solid.
5',3'-o-Diacetyl-0 6-nitrophenylethyl-deoxyguanosine (2)
5',3'-o-Diacetyl-deoxyguanosine (1) (2 g, 5.69 mmol)
64
nitrophenylethanol (1.43 g, 8.54 mmol) and
triphenylphosphine (2.98 g, 11.4 mmol) were dissolved in
100 ml of dioxane under argon. After 15 minutes of
stirring, diisopropyl azidocarboxylate (2.25 ml, 11.4 mmol)
was added slowly to the cloudy solution which subsequently
turned into a clear yellowish color. After 4 hours, the
solvent was removed in vacuo. The residue was dissolved in
200 ml of CH2C12. The organic layer was washed with
saturated aqueous NH4C1 (250 ml X 2), dried over anhydrous
MgSO4, filtered and the solvent was removed in vacuo.
Purification of the residue by silica gel chromatography
eluting with a gradient of neat CH2C12 to 50:1 CH2C12/MeOH
afforded a semi-pure yellow solid 3.01 g (106%).
5'3' -o-Diacetyl-0 6 -nitrophenylethyl-deoxyxanthosine (3)
5',3' -o-Diacetyl-0 6 -nitrophenylethyl-deoxyguanosine (2)
(1.29 g, 2.87 mmol) was dissolved with 7.5 ml of acetone. A
solution of sodium nitrite (5 g) in 15 ml of distilled water
was added to the solution. Acetic acid was added to the
reaction mixture and was allowed to stir for 2 hours. The
cloudy yellowish solution was quenched with saturated
bicarbonate and diluted with 100 ml of EtoAc. The aqueous
layer was washed with EtoAc (100 ml X 2) and the combined
organic layers were dried over MgSO4 , filtered and the
solvents were removed in vacuo. Purification of the solid
was accomplished by silica gel chromatography eluting with a
gradient (methylene chloride: methanol) (100:1, 50:1, 25:1).
The product yield was 0.77 g, a recovery of 53.6%.
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5' ,3' -o-Diacetyl- [ (02, 06) -dinitrophenylethyl] -
deoxyxanthosine (4)
5'3' -o-Diacetyl-0 6 -nitrophenylethyl-deoxyxanthosine (3) (256
mg, 0.51 mmol), nitrophenylethanol (129 mg, 0.77 mmol) and
triphenylphosphine (268 mg, 1.02 mmol) were dissolved in
10 ml of dioxane. Diisopropyl azidocarboxylate (200 1,
1.02 mmol) was added to the solution and stirred for 2 hours
at room temperature. The dioxane was removed and the
resulting semi-solid was dissolved in CH2C12 and washed once
with NH4C1. The CH2C12 layer was dried over MgSO4, filtered
and the solvents were removed in vacuo. Purification by
silica gel chromatography eluting with a gradient of neat
CH2Cl2 to 100:1 CH2Cl2/MeOH afforded a semi-pure yellow solid
375 mg (102%).
5',3' -o-Dihydroxyl- [ (02, 06) -dinitrophenylethyl] -
deoxyxanthosine (5)
Semipure (4) (335 mg, 0.52 mmol) was dissolved in 20 ml of
methanol. Ammonium hydroxide (20 ml) was added and allowed
to stir overnight. The solvents were evaporated and the
remaining white precipitate was dissolved with methylene
chloride (200 ml) and was washed with aqueous saturated
bicarbonate solution (100 ml). The organic layer was dried
over MgSO4, filtered and the solvents were removed in vacuo.
The crude material was purified by silica gel chromatography
eluting with a gradient of 75:1 dichloromethane/methanol to
10:1 CH2C12/MeOH to afford 199 mg (70.4%) of a white solid.
A H-NMR of 5',3' -o-dihydroxyl- [ (02, 06) -dinitrophenylethyl] -
deoxyxanthosine (5) is displayed (see figure 10).
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5' -Dimethoxytrityl,3' -hydroxyl-o- [(02,06) -
dinitrophenylethyl] deoxyxanthosine (6)
To a solution of 50 mg (0.088 mmol) of compound (5) in
160 Al of distilled pyridine were added 33 mg (0.1 mmol) of
dimethoxytrityl chloride. The solution was stirred for
6 hours at room temperature then concentrated. Purification
of the crude material by silica gel chromatography eluting
with a gradient of neat CH2C12 to 50:1 CH2C12/MeOH afforded
25 mg (32.7%) of 5'-protected product.
5' -Dimethoxytrityl,3'-phophoamidite-o-
(02, 06) dinitrophenylethyl] deoxyxanthosine (7)
To a solution of 25 mg (0.029 mmol) of compound (6) in
250 Al of CH2C12 were added 4 mg (0.02 mmol) of
diisopropylammoniium tetrazoldide (4 mg) and 11 Al (0.035
mmol) of bis-diisopropylamine 2-cyanoethyl phosphate. The
solution was stirred under argon for 6 hours. The solvent
was evaporated and the residue was purified by silica gel
chromatography eluting with 4:1 EtoAc:Hexane to afford 28 mg
(91.1%) of product. Mass spectrometry reveal a product
weight of 1066 a.m.u. and a molecular formula of C,,H59012N8P.
Incorporation of 5'-dimethoxytrityl, 3'-phophoamidite-o-
[(O2,06) dinitrophenylethyl]-deoxyxanthosine (7) into a
pentamer (5'-XCAGC-3') oligonucleotide.
5' -dimethoxytrityl,3'-hydroxyl-o- [(02,06)
dinitrophenylethyl] deoxyxanthosine (7) was dissolved in
acetonitrile (250 Al). A DNA synthesizer was used to
construct the modified pentamer with a coupling efficiency
of 56.9%. Elution of the pentamer from the column was
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accomplished with 2 ml of ammonium hydroxide. The residual
pentamer was stored at -20 °C subsequent to ammonium
hydroxide removal by lyophilization. The elimination of
protecting groups from 2'-deoxyxanthosine oligonucleotide
was performed by Mr. Esequiel Barrera.
Removal of protection groups from 2'-deoxyxanthosine
modified oligonucleotide
The methodology used for removal of protecting groups from
5'-dimethoxytrityl, 3'-phophoamidite-o-[(02,06)
dinitrophenylethyl]-deoxyxanthosine (7) incorporated into a
pentamer oligonucleotide sequence was described by Eritja et
al., 1986.
The white solid (7) (250 g) was added to a solution of
0.5 M of 1,8-diazabicyclo (5.4.0) undec-7-ene (38 1l)
dissolved in pyridine (462 Al) under argon. The reaction
was incubated for 4 hours at room temperature. After
lyophization the yellow-oily solution was passed through a
Sephadex G-10 size exclusion column (1.5 cm X 15 cm). The
product eluted after 40 ml of water as determined by UV
photometric 260 analysis. Speedvac condensation of the
product yielded 62.5 g (24%). The white precipitate was
dissolved in water and reacted with concentrated NH40H
(1 ml) for 16 hours at 65 0C to remove the remaining
5'dimethoxytrityl protection groups and lyophized. Product
purification was accomplished by HPLC. Small aliquots of
product were saved after each manipulation, and later
analyzed by HPLC to monitor reaction progress (see Figure
11).
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C. Purification and characterization of synthesized
oligonucleotides
All pentamer sequences (5'-XCAGC-3', 5'-GCIGC-3',
5'-GCAGC-3', 5'-GCUGC-3', and 5'-UCAGC-3') were purified by
reverse phase HPLC. Initial oligonucleotide separations
deployed a Waters HPLC system with a semi-preparatory C18
reverse phase column and a flow rate of 3 ml/min. The
gradient solvent system consist of 0-40% of 0.1 M ammonium
acetate/acetonitrile for 40 mins followed by steady-state
for 10 mins then by 10 mins at 100% acetonitrile. Final
oligonucleotide purification was accomplished by using a
Hewlett Packard HPLC system with an analytical C18 reverse
phase column and a flow rate of 1 ml/min. The solvent
system is the same as above except for the gradient of 0-20%
of 0.1 M ammonium acetate/ acetonitrile. The HPLC detection
limits were set at 2101, 2541, 260 and the threshold at 0.5
mAU. Salt-free oligonucleotide were accomplished with a
SepPak cartridge (Waters) eluted with a 50% mixture of
MeOH:H20. Sample recovery is 65% as measured by UV
absorption X254. Oligonucleotide molecular weight were
determined by laser deabsorption mass spectrometry, when
applicable.
Construction of abasic-site standards
Two HPLC abasic-site containing oligonucleotides
(5'-GC*GC-3' and 5'-p*CAGC-3') were constructed. The symbol
(*) denotes location of an abasic site. The abasic sites
are a consequence of 5-'GCUGC-3' and 5'-pUCAGC-3' incubation
with E. coli uracil DNA glycosylase (Sigma). The 5' uracil
of 5'-UCAGC-3' had to be phosphorylated prior to uracil
glycosylase application as noted by Varshney and
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van de Sande (1991). Kinase and uracil glycosylase assay
conditions are described in Maniatis et al., 1989.
Pentamer stability studies
Initially deoxyxanthosine and later deoxyxanthosine in a
pentamer oligonucleotide were tested for stability under
conditions necessary for genome construction (Green et al.,
1984; Wood et al., 1990). Incubations of modified
oligonucleotides (5'-GCIGC-3' and 5'-XCAGC-3') were tested
at various temperatures (37 C, 65 C, 100 C) and pH (6.6,
7.0, 7.5, 8.0) of 0.1 M Tris-HC1 buffer for durations of
3-30 min. Degradation products were analytically determined
by HPLC as noted above.
Enzymatic digestion of modified pentamer sequences
Bovine intestinal mucosa alkaline phosphatase I (1 unit,
Sigma), snake venom phosphodiesterase I (2.5 units, Sigma)
and pure oligonucleotides (2 g, 1.42 nmole) were added to
0.1 M Tris-HC1, 5 mM MgCl2 (pH 8.5) and incubated for 4
hours at 37 C. Afterwards the solution was filtered with a
0.45 m probind cartridge and microcentrifuged for 2 min.
Individual nucleosides were determined using a C18 reverse-
phase analytical column (Beckman), Hewlett Packard HPLC
system and a flow rate of 1 ml/min. Calibrated nucleoside
standards were used to help identify digested modified
oligonucleotides. All nucleosides are commercially
available except for deoxyxanthosine, which was synthesized
by Mr. William Kobertz. The same solvent system as above
was used with exception of the programmed gradient: 0-20%
of 0.1 M ammonium acetate/acetonitrile (60 min), followed by
steady-state for (5 min) then 20-100% of acetonitrile
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(10 min). Nucleoside extinction coefficients values
(Maniatis et al., 1989) are: 11.7 ml/Amole (dG), 7.3
ml/Aimole (dC), 15.4 ml/Amole (dA), 11.4 ml/lmole, (dX,
Moschel and Keefer, 1989) and 12.3 ml/Amole, (dI,
Specifications and criteria for biochemical compounds,
1967).
D. Bacteriophage and host bacteria
DL7 E. coli cells is the host cell for transfection of the
M13mp19 phage. This is an excision repair-competent strain
that does not contain a functional lactose operon. This
cell strain is particularly useful due to low color
background when X-gal indicator is used. E. coli GW5100
cells are used as the indicator strain for the M13mp19 phage
transfected host cell. The GW5100 strain contain the F'
episome that is required by the M13 phage for infection.
M13 phage secreted by the transfected host cells can infect
the surrounding GW5100 cells, thus forming plaques. GW5100
cultures require the complementary portion of the lacZ'
a operon provided by the M13mp19 to create a functional
lactose operon. Details are described in the M13
Experimental System section and references therein.
E. Preparation and design of modified M13 genomes
M13 precursors necessary for gapped heteroduplex
construction
M13 precursors were given by Ms. Debbie Kruetzer and Dr.
Dipti Mathur. The precursor construction deployed the Muta-
gene M13 in vitro mutagenesis kit (Bio-Rad laboratories) and
methodology described by Kunkel et al., 1987. The (+)
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single-stranded uracil-containing DNA template was isolated
by growing recombinant bacteriophage M13mp19 in a dut-, ung-
F'+ E. coli cell strain with a uracil rich solution. The
E. coli dut-, ung- mutant lacks the enzymes dUTPase and
uracil DNA-glycosylase, respectively. The precursor
construction entails a two step manipulation deploying two
primer sequences.
41 mer: 5'-GGGATCCTCTAGAGTCGACCGTGCAGGCATGCAAGCTTGGC-3'
45 mer: 5'-AACGACGGCCAGTGAATTCGGCTGCAGCTCGGTACCCGGGGATCC-3'
Purification of 41 mer and 45 mer primers was accomplished
by a running a 12.5% polyacrylamide gel. Both primers are
complementary to the (+) single-strand of the M13mp19 genome
except for 1 and 5 base areas denoted in bold which give
rise to small "bumps". The bumps are specifically located
opposite unique PstI and SacI restriction site of the lacZ'
a gene. Initially the phosphorylated 41 mer is annealed to
the ss uracil-containing (+) DNA strand. Subsequent
completion of the (-) strand is accomplished by T4 DNA
polymerase, dNTPs and T4 DNA ligase. Transfection of
isolated ds phage DNA into an E. coli (ung+, dut+) strain
destroy the uracil-containing (+) strand forcing replication
from the (-) strand. The resulting progeny has a single
base insert at the PstI site, named the M13mpl9+1 genome.
Using the M13mp19+1 genome as a template, the same
methodology is repeated using the 45 mer. The subsequent
five-base insertion at the SacI site forms the genome
M13mp19+6 (see Figure 12).
M13mpl9+1 and M13mpl9+6 characterization
RF phage DNA (1 g) was treated with PstI or SacI
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restriction enzymes and separated by 0.8% agarose gel
electrophoresis. RF DNA that showed the desired
characteristics (19+1, PstI resistance) and (19+6, SacI
resistance) were selected for further amplification after
DNA sequence verification. The mutant amplified RF
population was retransformed into DL7 cells and the progeny
was used to infect GW5100 cells to produce a second RF
population as noted below.
Amplification of M13 precursor genomes
Overnight GW5100 cell culture (100 l), 2x YT media (1 ml)
and a single plaque were incubated for 6 hours on a rotatory
drum at 37 C. An additional liter of 2x YT media was added
to the GW5100/phage culture and incubated for 8 hours. The
culture was put on ice for 30 min and centrifuged (7000 RPM,
10 min). The supernatant contained the ss phage and
the precipitate held the RF DNA. The supernatant was
further treated with 29.2 g of NaCl/liter and 40 g PEG 8000
and stirred at 4 C for 30 min. Centrifugation (10,000 RPM,
30 min) allowed for ss phage pellet formation. Small-scale
RF DNA extractions (phage miniprep kit, Promega) coupled
with an 0.8% agarose gel electrophoresis were used to detect
miniphage presence. Cultures containing miniphage were
discarded. Large scale RF or ss phage DNA isolation was
accomplished with a Maxi-prep DNA purification kit (Qiagen)
or by phenol extraction (Maniatis et al., 1989). Purity of
the DNA was verified by monitoring A260/A280 ratios and by
running aliquots on a 0.8% agarose gel and straining with
ethidium bromide. Electrophoretic conditions were set at
100 volts with constant current and a 2 hour run time.
RF DNA to be used for heteroduplex construction required
removal of minor contaminants consisting of nicked, linear,
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and ss DNA species. RF DNA contaminants were separated
after centrifugation using a 5-20% sucrose density gradient
(see Maniatis et al., 1989) and analyzed by gel-
electrophoresis as noted earlier. RF DNA/sucrose fractions
were collected and the sucrose removed by microdialysis at
4 C (dialysis membrane, Gibco-BRL, catalogue no. 1202MF).
Pure RF DNA was obtained after ethanol precipitation.
Transfection and plating of progeny phage
Overnight cultures of GW5100 (grown in 2x YT media) or DL7
(grown in LB media) cells were allowed to reach confluence.
An aliquot of DL7 (2 ml) overnight culture was used to
commence a fresh DL7 cell culture (250 mL) until the log
phase growth of 90-100 Klett units was obtained. The
standard plating assay is described by Messing, (1983).
Phage ss DNA (200 ng per sample) was mixed with about
2 X 109 transformation (CaCl2) competent DL7 cells and left
on ice for 60 min. Afterwards the samples were heat-shocked
(42 0C) for 1.5 min and chilled on ice again for an
additional 1.5 min. Serial dilutions of transfected cells
were add to a mixture of overnight GW5100 cells (300 l),
isopropyl-o-D-thiogalactoside (10 l, [24 mg/ml]), 5-Bromo-
4-chloro-3-indoly--D-galactopyranoside (40 l, [40 mg/ml]
in dimethylformamide), and 2.5 ml of melted agar (42 C)
then immediately plated on B-broth agar plates. Plaque and
color development occurs in 1 to 2 days. The presence of a
mutant bacteriophage can be detected by the colorless or
light blue plaque as compared to the normal dark blue color
of wild type plaques.
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Construction of heteroduplex genome with a five base gap
As a result of base insertions, the M13mpl9+1 genome has an
out of reading frame destroyed PstI site and gives rise to
colorless plaques. The M13mp19+6 genome has a restored
reading frame with regained PstI susceptibility and yields
dark blue plaques. A similar case is noted by Wood et al.
(1990). The gapped heteroduplex construction uses 50%
mixtures of M13mpl9+1 SacI linearized DNA and M13mp19+6
BglII linearized DNA. The BglII restricted DNA is further
treated with calf intestinal phosphatase (Sigma) to remove
5' phosphates this prevents self-religation. The two
linearized genomes are heat denatured and allowed to
hybridize (see Figure 13). The resulting five base gapped
heteroduplex is engineered to accept the ligation of the
generic oligomer sequence 5'-GCAGC-3'. A second gapped
molecule could also form but will pose no complication for
the reasons presented by Wood et al. (1990).
Pentamer sequence flexibility for gapped heteroduplex
ligation
The pentamer sequence was carefully design to carry out
site-specific mutagenic studies of deoxyxanthosine,
deoxyinosine and a host of other possible mutagenic lesions
(see Figure 14). The pentamer sequence is complementary to
the five-base gap of the heteroduplex.
3' ..... CTCGACGTCGG .....5' (-) strand of M13mp19+6
5' .....GAGCTGCAGCC .....3' (+) strand of M13mpl9+1
XCAGC
GCIGC
The underlined area denotes the generic pentamer ligated to
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the five-base gap. The modified pentamer sequences
(5'-pXCAGC-3' and 5'-pGCIGC-3') are designated to also
ligate to above gap. The first position of the 5' end of
the generic pentamer sequence was chosen as the site for
deoxyxanthosine incorporation. This location allowed for
less chemical exposure of the deoxyxanthosine-
phosphoramidite as the oligonucleotide was chemically
synthesized 3'-5'. The fourth position of the same pentamer
sequence is another suitable location for deoxyxanthosine.
The pentamer sequence carrying a single oxidative lesion is
5' phosphorylated and later ligated into the gapped
heteroduplex forming a singularly modified ds genome. The
non-ligatable nicked (-) strand is heat degraded leaving a
ss modified (+) genome ready for cell transfection and
biological evaluation (see Figure 15).
DNA sequencing of mutants
The dideoxynucleotide chain termination DNA sequencing
method (Sanger et al., 1977) was used to sequence the lacZ'
a gene, a 380 base pair region from position 6100-6480.
Reagents were provided by a DNA sequencing kit (Sequenase,
version 2, United States Biochemical Corporation). Two
short single stranded primers were annealed to the M13 phage
DNA, one at a site adjacent to the lacZ' a region and one
within the gene. The following primers were used: P6331
AAG TTG GGT AAC GCC and P6527 GTT TGA GGG GAG GAC. These
primers are complementary to the circular ss DNA and the
above number designates the 5' nucleotide position to which
the primer anneals in the M13mp19 genome. The complementary
strand synthesis is done by DNA polymerase in the presence
of the four deoxynucleotide triphosphates (dNTPs). The
incorporation of the ddNTPs terminates the synthesis of the
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strand and result in double stranded DNA products of
different lengths. After heating these products briefly at
95 C in formamide, the reactions are loaded onto adjacent
lanes of a denaturing 6% acrylamide gel. The presence of
7 M urea prevents complementary strands from reannealing to
each other during electrophoresis. The 35S labeled
fragments are detected by autoradiography and the sequence
deduced from the band pattern. The gel was dried and
exposed to X-ray film for 1-5 days at room temperature.
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Figure 9. Precursors of chemically protected
2'-deoxyxanthosine. The p-nitrophenol
ethyl protecting group (NPE) is linked to the
sixth position of guanine. Subsequently, the
amino group of guanine is deaminated and
oxidized to a carbonyl group. The
phosphoramidite deriative is formed and
incorporated into the pentamer with the NPE
group still covalently attached. Further
chemical deprotection, purification and
characterization was carried out prior to
oligonucleotide stability studies.
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Figure 10. Proton nuclear magnetic resonance spectrum of
diprotected deoxyxanthosine. After NMR
characterization, fully and partial
deprotected xanthine nucleoside where later
used to provide nucleoside standards to
monitor chemical deprotection treatment.
These standards also revealed that xanthine
in an oligonucleotide contains a stable
glycosidic bond under conditions necessary
for genome construction.
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Figure 11. Deprotection flow chart of xanthine
containing oligonucleotide. Removal of
p-nitrophenyl ethyl (NPE) protecting groups
were accomplished in a series of chemical
steps. After each chemical manipulation
small aliquots were saved and subsequently
analyzed by high pressure liquid
chromatography and ultra violet spectroscopy.
This process served as reaction monitors of
the chemical deprotection series.
Ultimately, the deprotected oligonucleotides
were purified, characterized and used for
stability studies of the oligonucleotide
under chemical conditions necessary for
genome construction.
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Figure 12. Recombinant DNA construction of gapped
heteroduplex precursors. Wild type M13mp19
was modified by insertion of a cytosine at a
PstI site in the LacZ' gene by standard
genetic techniques. The newly added
nucleotide forms the M13mpl9+1 genome and is
refractory to PstI digestion. The M13mp19+1
serves as a precursor for the further
addition of five bases at a SacI site
downstream of the initial singular insertion.
This genome is noted as M13mp19+6 and
regains a functional PstI site although
subsequently refractory to SacI digestion.
Both the 19+1 and 19+6 genomes are employed
for gapped heteroduplex construction.
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Figure 13. Specific details in the construction of the
gapped heteroduplex genome. The M13mp19+1 was
linearized with SacI restriction and mixed
with M13mp19+6 linearized with BglII and
dephosphorylated. Calf intestinal
phosphodiesterase (CIP) removes the phosphate
at the 5' end of the DNA strand which
effectively inhibits oligonucleotide self-
religation. Heteroduplex formation was
accomplished by heating and cooling with
fifty percent mixtures of M13mp19+1 and
M13mpl9+6.
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Figure 14. Modified pentamer sequence carrying various
oxidative lesions. The gapped heteroduplex
is complementary to the pentamer insert
carrying the modified nucleotide. This study
focuses on xanthine (X) and hypoxanthine (Hx)
modified oligonucleotides. However, other
nucleotide sites on the pentamer can be used
to measure the genotoxicity of other
oxidative lesions. In the figure, M13-NO
denotes the gapped heteroduplex formation.
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Figure 15. Construction of single stranded M13
genome containing a single lesion. The
positive sign (+) in the figure denotes the
M13mpl9+1 genome and the negative symbol
(-)denotes the M13mpl9+6. The five base gap
formed in the heteroduplex is formed by the
union of plus and negative strands. This gap
allows for complementary base pairing of the
pentamer carrying a modified nucleoside to be
placed directly in the gap. Prior to genome
transfection into E. coli, the minus strand
not containing the modified nucleoside is
removed. The remaining modified, single
stranded genome allows for mutagenic
measurement of the lesion independent of
repair mechanism present in E. coli.
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IV. Results
HPLC analysis after xanthine-containing pentamer
deprotection noted 8.5% abasic site and 33% 5'-XCAGC-3' of
the total reaction mixture. The retention time difference
between both species is 0.8 min (Table 1). Finer separation
of the 5'-XCAGC-3' from the AP species of 5'-XCAGC-3'
typically yield 65% of amount injected. The digestion of
modified oligonucleotides (Figure 16) and comparison with
controls (Table 2) confirm the expected nucleoside ratios
and complete removal of 5'-XCAGC-3' protecting groups.
Distinctive UV spectra of nucleosides (Figure 17) helped
determine the various nucleoside species. The
identification of the 5'-XCAGC-3' AP species was verified by
the absence of deoxyxanthosine. Further analysis of the 5'-
GCIGC-3' by mass spectrometry was found to yield a molecular
weight of 1488 a.m.u. (Figure 18).
Both modified pentamers (5'-XCAGC-3' and 5'-GCIGC-3') are
stable for conditions necessary for genome construction
(Wood et al., 1990). Specifically, the 5'-XCAGC-3' pentamer
showed only a single HPLC peak (no signs of degradation)
under heating conditions of 100 C for 3.5 min. A separate
study conducted at the same temperature for 3 min using
deoxyxanthosine was also stable but incubation for 5 min
showed signs of product degradation. The 5'-XCAGC-3' under
kinase reaction conditions (37 C, 30 min, 65 C, 15 min, pH
7.8) demonstrated a stable product however a minute shoulder
was detectable. The unidentified shoulder represents less
than 1% of the HPLC peak area. The potential problem of
readily labile glycosidic N-4' to C-l' links in
deoxyxanthine containing oligonucleotides, particularly in
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acidic environments, was not observed in conditions required
for genome fabrication. The 5'-GCIGC-3' is a very stable
species from pH 6.6-7.5 and no evidence of instability was
noted at 100 C.
Using genetic engineering techniques, a five-base gapped
heteroduplex genome was constructed. The gap position was
made complementary to various single-lesion containing
pentamer sequences. Possible mutations that arise from
deoxyxanthosine (X) and deoxyinosine (I) are devised to
convey progeny PstI resistance. Specifically, the PstI
recognition site (in bold, showing only one strand),
5'...CTGCAGC...3' contains the described 5'-GCAGC-3'
sequence. Premutagenic sequences 5'-XCAGC-3' and
5'-GCIGC-3' could give rise to GA and A-G transitions,
respectively, which change the PstI recognition sequence
(underlined) to 5'...CTACAGC...3' and 5'...CTGCGGC...3'.
This sequence change makes the PstI site non-functional.
Using the above characteristic, spontaneous DNA mutations
not associated with the specific lesion region (PstI site)
can be removed by rounds of PstI restriction. Attributes of
the lacZ' gene mutation assay expresses both spontaneous and
lesion-induced mutations. Therefore, enrichment of mutant
progeny by PstI restriction ensures more quantitative
results. The M13 genome design and mutation selection
scheme presented in this thesis will facilitate the future
site-specific mutagenic studies of deoxyxanthosine and
deoxyinosine in vivo.
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Table 1. HPLC retention marks of various pentamer
sequences. Stability of oligonucleotides was
analyzed under various pH (6-8) and
temperatures (100 C, 3.5 min, 37 C, 15 min)
necessary for genome construction. The
following symbol (*) denotes an abasic site
location in the pentamer sequence.
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HPLC RETENTION MARKS
GRADIENT 0-40% 0.1 M AMMONIUM ACETATE:ACETONITRILE
SAMPLE (MINS)
5'-GCAGC-3'
5'-GCAGC-3'
5'-GCAGC-3'
5'-GCAGC-3'
5'-GCIGC-3'
5'-GCIGC-3'
5'-GCIGC-3'
5'-GCIGC-3'
5'-GCUGC-3'
5'-GCUGC-3'
5'-GC*GC-3'
5'-UCAGC-3'
5'-UCAGC-3'
5'-UCAGC-3'
5'-UCAGC-3'
5'-*CAGC-3'
5'-XCAGC-3'
5'-XCAGC-3'
(semi-prep)
(analytical)
(pH stability)
(genome stability)
(semi-prep)
(analytical)
(pH stability)
(genome stability)
(semi-prep)
(analytical)
(abasic site)
(semi-prep)
(analytical)
(5' hydroxyl)
(5' phosphate)
(abasic site)
(abasic site,
(semi-prep)
semi-prep)
GRADIENT 0-20% 0.1 M AMMONIUM ACETATE:ACETONITRILE
5'-XCAGC-3' (abasic site, analytical)
5'-XCAGC-3' (analytical)
5'-XCAGC-3' (genome stability)
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29.7
24.5
25.6
25.1
31.4
24.6
24.3
24.2
30.9
25.8
23.5
35.8
23.3
27.8
23.2
20.2
28.7
29.5
29.5
30.3
30.1
Figure 16. Enzymatic digestion of modified pentamers
containing either deoxyinosine (dI) or
deoxyxanthosine (dX). Cytosine and xanthine
have a similar retention time but distinctive
ultraviolet spectra. This difference
allowed for further characterization of this
pentamer. All digested nucleoside ratios are
consistent with expected values as compared
to quantified standards.
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Table 2. HPLC retention marks for enzymatic digestion of
pentamers and nucleosides standards. HPLC
retention marks where obtained using an
analytical high pressure liquid reverse-phase
(C18) column. A 0-20% solvent gradients of 0.1
molar mixture of ammonium acetate to
acetonitrile was used to achieve resolution
over a run time of 75 min.
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OLIGONUCLEOTIDE ENZYMATIC DIGESTS
HPLC RETENTION TIMES
GRADIENT 0-20% 0.1 M AMMONIUM ACETATE:ACETONITRILE
SAMPLE
5'-GCAGC-3' (undigested)
5'-GCAGC-3' (digested)
dA
dC
dG
5'-GCIGC-3' (undigested)
dC
dG
dI
5'-GCAGC-3'
dA
dC
dG
5'-XCAGC-3'
5'-XCAGC-3'
dA
dC
dG
5'-XCAGC-3'
5'-XCAGC-3'
dA
dC
dG
dX
(control, digested)
(abasic site undigested)
(abasic site undigested)
(undigested)
(digested)
SYNTHESIZED STANDARDS
DEOXYXANTHOS INE
DEOXYXANTHOS INE
DEOXYXANTHOSINE
PEAK #1
PEAK #2
(MONOPROTECTED)
(DIPROTECTED)
99
(MINS)
30.1
29.2
13.6
21.7
29.6
13.6
21.7
20.7
35.7
14.3
25.5
29.7
36.1
14.5
25.8
29.8
36.1
14.5
25.7
14.0
14.1
51.7
53.9
56.3
Figure 17. The ultra violet spectra of nucleosides
following enzymatic digestion. Each spectrum
is arranged according to retention time as
eluted from a C18 reverse phase HPLC column.
The y-axis denotes milli-absorbance units
(mAU) and the x-axis is the wavelength of
light in nanometers (nm). All spectra were
taken using a deuterium light source and
multi-wave detector set at 210 nm, 254 nm and
260 nm.
100
oV4
3
D
Xcj
Ie-I AIe z, ueoxycyciine
a:
250 300 350 400 250 300 350 400
Havelength (no) Havelength (nm)
, 
13
ia
lao4,0#
3
a:
230 300 30E 400
ave length (non)
deox
4,
a
'I3
C
E
. I
:yguanosine
re 131 3 k18 380 400
Wavelength (nim)
101
F -. - ~ - I
3
6ii
250 300 35 488 
_ Wahelength (ion)
- -
, . .-
_~~~- -
__-9 r--r--r lil- r
.
Figure 18. Laser deabsorption mass spectrometry of
modified penatmer containing deoxyinosine.
The oligonucleotide retains a molecular weight
of 1488 atomic mass units.
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V. Discussion and future research
Site-specifically modified DNA oligonucleotides are
convenient models for probing the chemical and biological
effects of individual adducts (Basu and Essigmann, 1988).
The diversity of the adduct population following the
exposure of DNA to oxidants, nitric oxide or ionizing
radiation is likely to be the cause of the many different
types of mutations induced in genomes of mammalian
(Grosovsky et al., 1988; Nguyen et al., 1992), bacterial
(Glickman et al., 1980), and viral origin (Ayaki et al.,
1986; Hoebee et al., 1988). The mutational spectra observed
in these assay systems show a preference for single base
substitutions, the majority of which tend to be transitions
or transversions at GC pairs (Glickman et al., 1980; Ayaki
et al., 1986; Tindall et al., 1988; Hoebee et al., 1988;
Hayes et al., 1988; Moraes et al., 1989). Although much
work has been done on oxidative lesions there is uncertainty
as to which lesions give rise to the predominant G:C-A:T,
GC-TA and GC-CG mutations. The molecular lesion(s) giving
rise to the GC->TA transition could arise from the
deamination of an unstable oxidation product of cytosine
(Hayes et al., 1988). This hypothesis is being further
investigated by the Essigmann lab with the specific
candidates: 5-hydroxycytosine, 5-hydroxyuracil and uracil
glycol. Another possibility to account for the observed
G:C-A:T transition is purine deamination leading to the
formation of xanthine in DNA (Wink et al., 1991; Nguyen et
al., 1992, Kamiya et al., 1992b).
By using site-specific mutagenesis techniques as described
in this thesis, deoxyinosine, deoxyxanthosine and the above
cytosine derivatives could be studied in parallel. By using
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the same genetic system and pentamer sequence, conclusions
on the relative mutability of the various lesions can be
reached. Site-specific mutagenesis will allow us to rank
the mutagenic significance of each lesion studied. Results
from these studies combined with analytical information of
the amounts of each adduct present in cellular DNA, will
provide the basis for an estimate of the relative genetic
risks of the lesions formed by nitric oxide and oxygen
radicals. As mentioned earlier, site-specific mutagenesis
studies have been reported for hypoxanthine (Hill-Perkins et
al., 1986, Kamiya et al., 1992a) and xanthine (Kamiya et
al., 1992b). In the two latter works, only the qualitative
features of mutagenesis were reported (sequenced clones <
20). The proposed site-specific mutagenic experiment will
be a statistically more extensive study. The possible
mutations from the above base deaminations will give rise to
an amber codon enabling facile phenotypic detection of
mutants by their color on an indicator agar. Gross changes
in sequence (e,g., targeted deletions) affecting the
original adduct site are detectable but untargeted mutations
remote from the adduct site would probably be missed; such
mutations are expected to be rare.
Other future investigations of oxidative and nitric oxide
mutagenesis could deploy E. coli strains with different DNA
replication and repair backgrounds as demonstrated by Basu
et al., 1989. The influence of the inducible E. coli SOS
system on mutagenesis could be also examined (Lasko et al.,
1988). These studies are aimed at determining whether the
DNA lesions under investigation are mutagenic and, if so,
whether there are specific genetic requirements for that
mutagenesis. These studies would order the mutagenic
potential of DNA lesions in wild type cells. Additionally,
105
through the use of a mutant host, they also define the host
genes that effect these mutations, and the genes that
protect the cell against mutagenesis. The described lesions
showing mutagenic activity in bacterial cells will be tested
for mutagenesis in a mammalian site-specific mutagenesis
assay (Ellison et al., 1989). Observations of site-specific
mutagenic studies along with potential animal models
containing for example the lacZ' gene (Douglas et al., 1994)
are useful tools for in vivo detection and quantification of
induced gene mutation.
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